Schering-Plough proposes governance changes
497623
Drug maker Schering-Plough Corp.  said on Friday it is taking actions to improve corporate governance, including ending a "poison pill" anti-takeover provision and proposing directors be elected by a majority of votes cast instead of a plurality.
681922
Federal regulators proposed a plan on Tuesday to strengthen governance at stock exchanges and move them toward separating their self-policing functions from business operations to ensure that they serve investors&#39; interests.
750028
Shares in Schering dropped on Friday  after the German drugmaker said U.S. regulators needed more  information to approve its key Bonefos drug for use in  preventing bone tumors in breast cancer patients.
543697
Health and Human Services Secretary Tommy Thompson is expected to announce changes to give the FDA's Office of Drug Safety more autonomy.
96149
BRUSSELS, Jan 17 (IPS) - European environmental groups are preparing to  challenge business groups this week over new EU proposals that  aim to cut out dangerous chemicals.
393977
The U.S. Food and Drug Administration said on Tuesday it would make organizational changes to improve internal communication about potential risks that emerge after a new drug reaches the market.
122773
The drugmaker Bayer AG said Friday that it will cut 6,100 jobs, or 5.5 percent of its work force, as it integrates Schering AG into its health care unit. More than half of the cuts will be in Europe, but about 1,000 positions will be eliminated in the United States.
643086
The U.S. presidential election in November could force change at the top of the Securities and Exchange Commission and help decide the fate of a reform effort to give shareholders more boardroom power.
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
531621
Schering gets an expanded label and begins marketing another drug overseas.
205867
German drug maker Schering, recently acquired by pharmaceuticals and chemicals giant Bayer, has said that it was teaming up with British drug giant AstraZeneca to develop a new treatment against breast cancer.
735826
A new face in the boardroom heralds change for the troubled company.
414190
FRANKFURT/CHICAGO  - U.S. regulators have demanded  more clinical studies of a new substance designed to produce  clearer MRI pictures of clogged arteries, Germany's Schering AG  and U.S. partner Epix Pharmaceuticals Inc. said on Friday.
692853
Schering-Plough Corp  said on Thursday that it expects to report higher sales of its cholesterol drugs Vytorin and Zetia in the fourth quarter of 2007 and in 2008 even though they face growing competition.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
504043
A body that advises the German  government on medical ethics on Monday recommended changing the  law to make stem cell research easier, a view that could boost  the chances of new legislation.
245551
Schering-Plough (SGP:NYSE - news - research) Monday announced a broad marketing agreement with Germany&#39;s Bayer (BAY:NYSE - news - research) that both companies said will lead to a more efficient use of their marketing and sales strengths.